Related Experiment Video
Updated: Jun 26, 2026

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
A data-driven tuberculosis model with behavioral changes and saturated treatment: Optimal control and
Pooja Khoda1, Tapan Sarkar2, Om Prakash Meena3
1Department of Mathematics, Shaheed Bhagat Singh College, University of Delhi, New Delhi 110017, India.
Abstract:
In this study, we develop a data-driven susceptible-exposed-infectious-treatment tuberculosis transmission model. The model incorporates a Holling type-II saturated incidence rate to capture behavioral and contact saturation effects, along with a Verhulst-type treatment function to reflect constraints in treatment capacity. Model parameters are estimated using India's tuberculosis (TB) incidence data from 2000 to 2020, yielding R0 = 1.4507, which indicates persistent disease transmission in the absence of effective interventions. To identify efficient control strategies, an optimal control problem is formulated by introducing three time-dependent interventions: preventive measures (u1), tuberculosis preventive treatment (u2), and active case finding (u3). The necessary optimality conditions are obtained using Pontryagin's maximum principle, and the resulting system is solved numerically. Two intervention scenarios are examined: a baseline scenario with limited intervention efficacy (τ = 0.15, θ = 0.05) and an enhanced scenario with improved efficacy parameters (τ = 0.60, θ = 0.67). A comprehensive cost-effectiveness analysis is conducted using incremental averted ratio, Average Cost-Effectiveness Ratio (ACER), and Incremental Cost-Effectiveness Ratio (ICER) to compare competing intervention strategies. The analysis shows that, under the baseline efficacy, strategy E (u1 only) emerges as the most impactful intervention for reducing transmission. Under the with-improvement scenario, strategy C (u1 + u3) demonstrates the most economically efficient, achieving the lowest ACER and most favorable ICER among all strategies considered. These findings provide evidence-based, cost-effective intervention strategies to guide policy formulation and accelerate India's progress toward the WHO End TB strategy milestones, including a 95% reduction in TB deaths and 90% reduction in incidence by 2035 relative to 2015 levels.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Therapeutic Drug Monitoring: Affecting Factors

